Showing results (131-140 of 232) with videos related to

Sort By:
Pageof 24
Oncogene|March 18, 2008
A role for Myc in facilitating transcription activation by E2F1J Y Leung, G L Ehmann, P H Giangrande, et al.
Molecular Cancer Research : MCR|October 29, 2005
A mechanism of COOH-terminal binding protein-mediated repressionAlison R Meloni, Chun-Hsiang Lai, Tso-Pang Yao, et al.
Cell Growth & Differentiation : the Molecular Biology Journal of the American Association for Cancer Research|March 5, 1998
E2F1-specific induction of apoptosis and p53 accumulation, which is blocked by Mdm2T F Kowalik, J DeGregori, G Leone, et al.
The EMBO Journal|March 12, 2004
Combinatorial gene control involving E2F and E Box family membersPaloma H Giangrande, Wencheng Zhu, Rachel E Rempel, et al.
Molecular and Cellular Biology|May 16, 2003
Identification of E-box factor TFE3 as a functional partner for the E2F3 transcription factorPaloma H Giangrande, Timothy C Hallstrom, Chainarong Tunyaplin, et al.
Cell Cycle (Georgetown, Tex.)|September 9, 2011
Network calisthenics: control of E2F dynamics in cell cycle entryJeffrey V Wong, Peng Dong, Joseph R Nevins, et al.
Proceedings of the National Academy of Sciences of the United States of America|July 5, 1994
Interaction of the Dr1 inhibitory factor with the TATA binding protein is disrupted by adenovirus E1AV B Kraus, J A Inostroza, K Yeung, et al.
Plos Biology|September 30, 2010
Stochastic E2F activation and reconciliation of phenomenological cell-cycle modelsTae J Lee, Guang Yao, Dorothy C Bennett, et al.
Molecular and Cellular Biology|July 1, 1983
Effect of adenovirus on metabolism of specific host mRNAs: transport control and specific translational discriminationA Babich, L T Feldman, J R Nevins, et al.
Plos One|August 29, 2009
Utilization of genomic signatures to identify phenotype-specific drugsSeiichi Mori, Jeffrey T Chang, Eran R Andrechek, et al.
Pageof 24